SPARK Profiled by ABC News
Posted on January 5th, 2019
In developing new drugs for rare diseases, this non-profit steps in when pharmaceutical companies won’t
A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain cancer drug, one that might have ended up overlooked by pharmaceutical companies.
The lead researcher on the team, Dr. Teresa Purzner has already beat impossible odds. The neurosurgeon and mom of three managed to get the approval in record time and with little money thanks to the help of a team of ‘scientific altruists’ called SPARK.
Read the full story here
Permalink: https://sparkmed.stanford.edu/spark-profiled-by-abc-news/